WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Hard Copy Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Pharmaceuticals: Canada Industry Guide

Datamonitor, February 2010, Pages: 68

The Pharmaceuticals: Canada Industry Guide is an essential resource for top-level data and analysis covering the Canada Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Scope of the Report

- Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

- Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

- Incorporates in-depth five forces competitive environment analysis and scorecards

- Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Highlights

- The Canadian pharmaceuticals market generated total revenues of $23,213.9 million in 2009, representing a compound annual growth rate (CAGR) of 5.6% for the period spanning 2005-2009.

- The Canadian OTC pharmaceuticals market generated total revenues of $2.4 billion in 2008, representing a compound annual growth rate (CAGR) of 3.6% for the period spanning 2004-2008.

- The Canadian biotechnology market generated total revenues of $4.5 billion in 2008, representing a compound annual growth rate (CAGR) of 4.6% for the period spanning 2004-2008.

- The Canadian generics market generated total revenues of $3.7 billion in 2008, representing a compound annual growth rate (CAGR) of 9% for the period spanning 2004-2008.

Why you should buy this report

- Spot future trends and developments

- Inform your business decisions

- Add weight to presentations and marketing materials

- Save time carrying out entry-level research

CHAPTER 1 BIOTECHNOLOGY IN CANADA
1.1 Market Overview
1.2 Market Value
1.3 Market Segmentation I
1.4 Market Segmentation II
1.5 Five Forces Analysis
1.6 Market Forecasts
CHAPTER 2 GENERICS IN CANADA
2.1 Market Overview
2.2 Market Value
2.3 Market Segmentation I
2.4 Market Segmentation II
2.5 Five Forces Analysis
2.6 Market Forecasts
CHAPTER 3 OTC PHARMACEUTICALS IN CANADA
3.1 Market Overview
3.2 Market Value
3.3 Market Segmentation I
3.4 Market Segmentation II
3.5 Market Share
3.6 Five Forces Analysis
3.7 Distribution
3.8 Market Forecasts
CHAPTER 4 PHARMACEUTICALS IN CANADA
4.1 Market Overview
4.2 Market Value
4.3 Market Segmentation I
4.4 Market Segmentation II
4.5 Market Share
4.6 Five Forces Analysis
4.7 Market Forecasts
CHAPTER 5 MACROECONOMIC INDICATORS
CHAPTER 6 APPENDIX
6.1 Data Research Methodology

LIST OF TABLES
Table 1: Canada Biotechnology Market Value: $ billion, 2004-2008
Table 2: Canada Biotechnology Market Segmentation I: % Share, by Value, 2008
Table 3: Canada Biotechnology Market Segmentation II: % Share, by Value, 2008
Table 4: Canada Biotechnology Market Value Forecast: $ billion, 2008-2013
Table 5: Canada Generics Market Value: $ billion, 2004-2008
Table 6: Canada Generics Market Segmentation I: % Share, by Value, 2008
Table 7: Canada Generics Market Segmentation II: % Share, by Value, 2008
Table 8: Canada Generics Market Value Forecast: $ billion, 2008-2013
Table 9: Canada OTC Pharmaceuticals Market Value: $ billion, 2004-2008
Table 10: Canada OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008
Table 11: Canada OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008
Table 12: Canada OTC Pharmaceuticals Market Share: % Share, by Value, 2008
Table 13: Canada OTC Pharmaceuticals Distribution: % Share, by Value, 2008
Table 14: Canada OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 15: Canada Pharmaceuticals Market Value: $ billion, 2005-2009
Table 16: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2009
Table 17: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
Table 18: Canada Pharmaceuticals Market Share: % Share, by Value, 2009
Table 19: Canada Pharmaceuticals Market Value Forecast: $ billion, 2009-2014
Table 20: Canada Size of Population (million) , 2004-2008
Table 21: Canada GDP (Constant 2000 Prices, $ billion), 2004-2008
Table 22: Canada Inflation, 2004-2008
Table 23: Canada Exchange Rate, 2004-2008

LIST OF FIGURES
Figure 1: Canada Biotechnology Market Value: $ billion, 2004-2008
Figure 2: Canada Biotechnology Market Segmentation I: % Share, by Value, 2008
Figure 3: Canada Biotechnology Market Segmentation II: % Share, by Value, 2008
Figure 4: Forces Driving Competition in the Biotechnology Market in Canada, 2008
Figure 5: Drivers of Buyer Power in the Biotechnology Market in Canada, 2008
Figure 6: Drivers of Supplier Power in the Biotechnology Market in Canada, 2008
Figure 7: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Canada, 2008
Figure 8: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Canada, 2008
Figure 9: Drivers of Degree of Rivalry in the Biotechnology Market in Canada, 2008
Figure 10: Canada Biotechnology Market Value Forecast: $ billion, 2008-2013
Figure 11: Canada Generics Market Value: $ billion, 2004-2008
Figure 12: Canada Generics Market Segmentation I: % Share, by Value, 2008
Figure 13: Canada Generics Market Segmentation II: % Share, by Value, 2008
Figure 14: Forces Driving Competition in the Generics Market in Canada, 2008
Figure 15: Drivers of Buyer Power in the Generics Market in Canada, 2008
Figure 16: Drivers of Supplier Power in the Generics Market in Canada, 2008
Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in Canada, 2008
Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in Canada, 2008
Figure 19: Drivers of Degree of Rivalry in the Generics Market in Canada, 2008
Figure 20: Canada Generics Market Value Forecast: $ billion, 2008-2013
Figure 21: Canada OTC Pharmaceuticals Market Value: $ billion, 2004-2008
Figure 22: Canada OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008
Figure 23: Canada OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008
Figure 24: Canada OTC Pharmaceuticals Market Share: % Share, by Value, 2008
Figure 25: Forces Driving Competition in the OTC Pharmaceuticals Market in Canada, 2008
Figure 26: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Canada, 2008
Figure 27: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Canada, 2008
Figure 28: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Canada, 2008
Figure 29: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Canada, 2008
Figure 30: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Canada, 2008
Figure 31: Canada OTC Pharmaceuticals Distribution: % Share, by Value, 2008
Figure 32: Canada OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 33: Canada Pharmaceuticals Market Value: $ billion, 2005-2009
Figure 34: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2009
Figure 35: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
Figure 36: Canada Pharmaceuticals Market Share: % Share, by Value, 2009
Figure 37: Forces Driving Competition in the Pharmaceuticals Market in Canada, 2009
Figure 38: Drivers of Buyer Power in the Pharmaceuticals Market in Canada, 2009
Figure 39: Drivers of Supplier Power in the Pharmaceuticals Market in Canada, 2009
Figure 40: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Canada, 2009
Figure 41: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Canada, 2009
Figure 42: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Canada, 2009
Figure 43: Canada Pharmaceuticals Market Value Forecast: $ billion, 2009-2014

Customers who bought this item also bought